筛选
科学数据
统计数据
共检索到1条 ,权限内显示50条;
Data from: Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic
- 负责人：
- DOI：
- doi:10.5061/dryad.71f1s18
- 摘要：
- Abemaciclib (Verzenio?) is approved as tyrosine kinase inhibitor (TKI) for breast cancer treatment. In this study, in vitro phase I
首页上一页1下一页尾页
